Asthma Therapy and Its Effect on Airway Remodelling

[1]  I. Pavord,et al.  Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: a 12-month follow-up analysis. , 2014, The Journal of allergy and clinical immunology.

[2]  E. Kerwin,et al.  Randomized, double-blind, placebo-controlled study of brodalumab, a human anti-IL-17 receptor monoclonal antibody, in moderate to severe asthma. , 2013, American journal of respiratory and critical care medicine.

[3]  B. Vickery,et al.  Apoptotic Cell Clearance by Bronchial Epithelial Cells Critically Influences Airway Inflammation , 2013, Pediatrics.

[4]  J. Bird,et al.  Mepolizumab for Severe Eosinophilic Asthma (DREAM): A Multicentre, Double-Blind, Placebo-Controlled Trial , 2013, Pediatrics.

[5]  M. Martins,et al.  Antileukotriene Reverts the Early Effects of Inflammatory Response of Distal Parenchyma in Experimental Chronic Allergic Inflammation , 2013, BioMed research international.

[6]  I. Pavord,et al.  Rationale and Clinical Results of Inhibiting Interleukin-5 for the Treatment of Severe Asthma , 2013, Current Allergy and Asthma Reports.

[7]  Machelle D. Wilson,et al.  Statin use and asthma control in patients with severe asthma , 2013, BMJ Open.

[8]  I. Pavord,et al.  Bronchial thermoplasty: Long-term safety and effectiveness in patients with severe persistent asthma. , 2013, The Journal of allergy and clinical immunology.

[9]  S. Wenzel,et al.  Dupilumab in persistent asthma with elevated eosinophil levels. , 2013, The New England journal of medicine.

[10]  C. Brightling,et al.  Origins of increased airway smooth muscle mass in asthma , 2013, BMC Medicine.

[11]  A. Husain,et al.  Endobronchial Biopsy: A Guide for Asthma Therapy Selection in the Era of Bronchial Thermoplasty , 2013, The Journal of asthma : official journal of the Association for the Care of Asthma.

[12]  J. Dai,et al.  Dexamethasone Inhibits Repair of Human Airway Epithelial Cells Mediated by Glucocorticoid-Induced Leucine Zipper (GILZ) , 2013, PloS one.

[13]  Shu-Juan Jiang,et al.  Efficacy of Anti-Interleukin-5 Therapy with Mepolizumab in Patients with Asthma: A Meta-Analysis of Randomized Placebo-Controlled Trials , 2013, PloS one.

[14]  C. Brightling,et al.  Airway Smooth Muscle Hypercontractility in Asthma , 2013, Journal of allergy.

[15]  M. Tamm,et al.  The Role of IgE-Receptors in IgE-Dependent Airway Smooth Muscle Cell Remodelling , 2013, PloS one.

[16]  Q. Lin,et al.  1,25‐Dihydroxyvitamin D3 Inhibits Nuclear Factor Kappa B Activation by Stabilizing Inhibitor IκBα via mRNA Stability and Reduced Phosphorylation in Passively Sensitized Human Airway Smooth Muscle Cells , 2013, Scandinavian journal of immunology.

[17]  Takahiro Matsumoto,et al.  Eosinophils Promote Epithelial to Mesenchymal Transition of Bronchial Epithelial Cells , 2013, PloS one.

[18]  Chan Sun Park,et al.  Metformin reduces airway inflammation and remodeling via activation of AMP-activated protein kinase. , 2012, Biochemical pharmacology.

[19]  I. Adcock,et al.  Statins as potential therapeutic drug for asthma? , 2012, Respiratory Research.

[20]  A. Chetta,et al.  Role of Inhaled Steroids in Vascular Airway Remodelling in Asthma and COPD , 2012, International journal of endocrinology.

[21]  A. Halayko,et al.  Muscarinic receptor stimulation augments TGF-β1-induced contractile protein expression by airway smooth muscle cells. , 2012, American journal of physiology. Lung cellular and molecular physiology.

[22]  Michael Engel,et al.  Tiotropium in asthma poorly controlled with standard combination therapy. , 2012, The New England journal of medicine.

[23]  P. Sly,et al.  Respiratory viral infections in children with asthma: do they matter and can we prevent them? , 2012, BMC Pediatrics.

[24]  S. Gunst,et al.  Point: alterations in airway smooth muscle phenotype do/do not cause airway hyperresponsiveness in asthma. , 2012, Journal of applied physiology.

[25]  C. Brightling,et al.  A phase II placebo-controlled study of tralokinumab in moderate-to-severe asthma , 2012, European Respiratory Journal.

[26]  R. Wu,et al.  Differential effects of simvastatin on IL-13-induced cytokine gene expression in primary mouse tracheal epithelial cells , 2012, Respiratory Research.

[27]  S. Wenzel Asthma phenotypes: the evolution from clinical to molecular approaches , 2012, Nature Medicine.

[28]  S. Royce,et al.  The regulation of fibrosis in airway remodeling in asthma , 2012, Molecular and Cellular Endocrinology.

[29]  G. Canonica,et al.  Omalizumab Modulates Bronchial Reticular Basement Membrane Thickness and Eosinophil Infiltration in Severe Persistent Allergic Asthma Patients , 2012, International journal of immunopathology and pharmacology.

[30]  Juan Luis Gutiérrez-Chico,et al.  Optical coherence tomography: from research to practice , 2012, European heart journal cardiovascular Imaging.

[31]  C. Brightling,et al.  Increased nicotinamide adenine dinucleotide phosphate oxidase 4 expression mediates intrinsic airway smooth muscle hypercontractility in asthma. , 2012, American journal of respiratory and critical care medicine.

[32]  T. Hackett Epithelial–mesenchymal transition in the pathophysiology of airway remodelling in asthma , 2012, Current opinion in allergy and clinical immunology.

[33]  M. Hoshino,et al.  Effects of Adding Omalizumab, an Anti-Immunoglobulin E Antibody, on Airway Wall Thickening in Asthma , 2012, Respiration.

[34]  S. Willsie Tiotropium improves lung function in patients with severe uncontrolled asthma: A randomized controlled trial , 2012 .

[35]  Lee, Jk,et al.  Lebrikizumab treatment in adults with asthma. , 2011 .

[36]  W. Banya,et al.  Relationship between serum vitamin D, disease severity, and airway remodeling in children with asthma. , 2011, American journal of respiratory and critical care medicine.

[37]  S. Johnston,et al.  Asthma exacerbations: Origin, effect, and prevention , 2011, Journal of Allergy and Clinical Immunology.

[38]  P. Howarth,et al.  Defective epithelial barrier function in asthma. , 2011, The Journal of allergy and clinical immunology.

[39]  S. Ghavami,et al.  Simvastatin inhibits TGFβ1-induced fibronectin in human airway fibroblasts , 2011, Respiratory research.

[40]  M. Castro,et al.  Persistence of effectiveness of bronchial thermoplasty in patients with severe asthma. , 2011, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[41]  P. Howarth,et al.  Effect of bronchoconstriction on airway remodeling in asthma. , 2011, The New England journal of medicine.

[42]  G. Damera,et al.  Does airway smooth muscle express an inflammatory phenotype in asthma? , 2011, British journal of pharmacology.

[43]  T. Ahmad,et al.  Simvastatin improves epithelial dysfunction and airway hyperresponsiveness: from asymmetric dimethyl-arginine to asthma. , 2011, American journal of respiratory cell and molecular biology.

[44]  Ching-Chi Lin,et al.  Effects of erlotinib on pulmonary function and airway remodeling after sensitization and repeated allergen challenge in Brown-Norway rats , 2011, Respiratory Physiology & Neurobiology.

[45]  Don D. Sin,et al.  The airway epithelium: more than just a structural barrier , 2011, Therapeutic advances in respiratory disease.

[46]  J. Whitsett,et al.  Epithelial EGF receptor signaling mediates airway hyperreactivity and remodeling in a mouse model of chronic asthma. , 2011, American journal of physiology. Lung cellular and molecular physiology.

[47]  Chan Kwon Park,et al.  Effect of Imatinib on Airway Smooth Muscle Thickening in a Murine Model of Chronic Asthma , 2011, International Archives of Allergy and Immunology.

[48]  S. Johnston,et al.  Rhinovirus infection induces expression of airway remodelling factors in vitro and in vivo , 2011, Respirology.

[49]  J. Fuxe,et al.  Chronic Respiratory Aeroallergen Exposure in Mice Induces Epithelial-Mesenchymal Transition in the Large Airways , 2011, PloS one.

[50]  J. Last,et al.  Simvastatin inhibits goblet cell hyperplasia and lung arginase in a mouse model of allergic asthma: a novel treatment for airway remodeling? , 2010, Translational research : the journal of laboratory and clinical medicine.

[51]  E. R. Sutherland,et al.  Tiotropium bromide step-up therapy for adults with uncontrolled asthma. , 2010, The New England journal of medicine.

[52]  C. Brightling,et al.  Ciliary dysfunction and ultrastructural abnormalities are features of severe asthma. , 2010, The Journal of allergy and clinical immunology.

[53]  G. Davies,et al.  Neutralisation of Interleukin-13 in Mice Prevents Airway Pathology Caused by Chronic Exposure to House Dust Mite , 2010, PloS one.

[54]  I. Pavord,et al.  Quantitative analysis of high-resolution computed tomography scans in severe asthma subphenotypes , 2010, Thorax.

[55]  K. Ohta,et al.  Effect of tiotropium bromide on airway inflammation and remodelling in a mouse model of asthma , 2010, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[56]  C. Lemière,et al.  T Cells localize with proliferating smooth muscle alpha-actin+ cell compartments in asthma. , 2010, American journal of respiratory and critical care medicine.

[57]  A. Alangari Genomic and non-genomic actions of glucocorticoids in asthma , 2010, Annals of thoracic medicine.

[58]  Tak H. Lee,et al.  Ca2+ homeostasis and structural and functional remodelling of airway smooth muscle in asthma , 2010, Thorax.

[59]  M. Mishima,et al.  Induced sputum concentrations of mucin in patients with asthma and chronic cough. , 2010, Chest.

[60]  I. Heijink,et al.  Epidermal growth factor receptor signalling contributes to house dust mite-induced epithelial barrier dysfunction , 2010, European Respiratory Journal.

[61]  C. Brightling,et al.  Airway smooth muscle proliferation and survival is not modulated by mast cells , 2010, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[62]  W. Henderson,et al.  An update on the role of leukotrienes in asthma , 2010, Current opinion in allergy and clinical immunology.

[63]  Mario Castro,et al.  Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter, randomized, double-blind, sham-controlled clinical trial. , 2010, American journal of respiratory and critical care medicine.

[64]  E. Hoffman,et al.  Glucocorticoid Efficacy in Asthma , 2010, Journal of Investigative Medicine.

[65]  S. Willsie Mepolizumab for Prednisone-Dependent Asthma with Sputum Eosinophilia , 2010 .

[66]  D. Postma,et al.  House dust mite-promoted epithelial-to-mesenchymal transition in human bronchial epithelium. , 2010, American journal of respiratory cell and molecular biology.

[67]  Mathieu Lederlin,et al.  Bronchial measurements in patients with asthma: comparison of quantitative thin-section CT findings with those in healthy subjects and correlation with pathologic findings. , 2009, Radiology.

[68]  E. Goncharova,et al.  Vitamin D inhibits growth of human airway smooth muscle cells through growth factor‐induced phosphorylation of retinoblastoma protein and checkpoint kinase 1 , 2009, British journal of pharmacology.

[69]  A. Miller-Larsson,et al.  Budesonide/formoterol effects on metalloproteolytic balance in TGFbeta-activated human lung fibroblasts. , 2009, Respiratory medicine.

[70]  P. Barnes Histone deacetylase-2 and airway disease , 2009, Therapeutic advances in respiratory disease.

[71]  S. Wenzel,et al.  Role of insulin-like growth factor binding protein-3 in allergic airway remodeling. , 2009, American journal of respiratory and critical care medicine.

[72]  D. McDonald,et al.  TNF-alpha drives remodeling of blood vessels and lymphatics in sustained airway inflammation in mice. , 2009, The Journal of clinical investigation.

[73]  R. Panettieri,et al.  Airway smooth muscle as an immunomodulatory cell. , 2009, Pulmonary pharmacology & therapeutics.

[74]  Stephen Lam,et al.  Quantitative assessment of the airway wall using computed tomography and optical coherence tomography. , 2009, Proceedings of the American Thoracic Society.

[75]  A Magnan,et al.  Masitinib, a c‐kit/PDGF receptor tyrosine kinase inhibitor, improves disease control in severe corticosteroid‐dependent asthmatics , 2009, Allergy.

[76]  D. Knight,et al.  Induction of epithelial-mesenchymal transition in primary airway epithelial cells from patients with asthma by transforming growth factor-beta1. , 2009, American journal of respiratory and critical care medicine.

[77]  J. Bousquet,et al.  Montelukast in guidelines and beyond , 2009, Advances in therapy.

[78]  C. Brightling,et al.  Airway wall geometry in asthma and nonasthmatic eosinophilic bronchitis , 2009, Allergy.

[79]  E. Jesudason,et al.  Airway smooth muscle: an architect of the lung? , 2009, Thorax.

[80]  E. Kerwin,et al.  A randomized, double-blind, placebo-controlled study of tumor necrosis factor-alpha blockade in severe persistent asthma. , 2009, American journal of respiratory and critical care medicine.

[81]  Ana Sousa,et al.  Mepolizumab and exacerbations of refractory eosinophilic asthma. , 2009, The New England journal of medicine.

[82]  S. Royce,et al.  Effect of extracellular matrix composition on airway epithelial cell and fibroblast structure: implications for airway remodeling in asthma. , 2009, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[83]  J. Gern Rhinovirus and the initiation of asthma , 2009, Current opinion in allergy and clinical immunology.

[84]  A. Bush,et al.  Pathophysiological features of asthma develop in parallel in house dust mite-exposed neonatal mice. , 2009, American journal of respiratory cell and molecular biology.

[85]  E. Hoffman,et al.  A multivariate analysis of risk factors for the air-trapping asthmatic phenotype as measured by quantitative CT analysis. , 2009, Chest.

[86]  Jie Zheng,et al.  Airway remodeling measured by multidetector CT is increased in severe asthma and correlates with pathology. , 2008, Chest.

[87]  C. Brightling,et al.  Mast Cells Promote Airway Smooth Muscle Cell Differentiation via Autocrine Up-Regulation of TGF-β11 , 2008, The Journal of Immunology.

[88]  D. Kim,et al.  The Effect of Interleukin-4 and Amphiregulin on the Proliferation of Human Airway Smooth Muscle Cells and Cytokine Release , 2008, Journal of Korean medical science.

[89]  K. Racké,et al.  Muscarinic receptors mediate stimulation of collagen synthesis in human lung fibroblasts , 2008, European Respiratory Journal.

[90]  E. Abraham,et al.  Activation of AMPK attenuates neutrophil proinflammatory activity and decreases the severity of acute lung injury. , 2008, American journal of physiology. Lung cellular and molecular physiology.

[91]  C. Liu,et al.  Glucocorticoids inhibit degranulation of mast cells in allergic asthma via nongenomic mechanism , 2008, Allergy.

[92]  H. Shirasawa,et al.  Tiotropium Bromide Attenuates Respiratory Syncytial Virus Replication in Epithelial Cells , 2008, Respiration.

[93]  D. Smallwood,et al.  Proliferation is not increased in airway myofibroblasts isolated from asthmatics , 2008, European Respiratory Journal.

[94]  Stephen Lam,et al.  Airway wall thickness assessed using computed tomography and optical coherence tomography. , 2008, American journal of respiratory and critical care medicine.

[95]  K. Rabe,et al.  Expression of smooth muscle and extracellular matrix proteins in relation to airway function in asthma. , 2008, The Journal of allergy and clinical immunology.

[96]  U. Grouven,et al.  Montelukast as add-on therapy to inhaled corticosteroids in the treatment of mild to moderate asthma: a systematic review , 2008, Thorax.

[97]  M. Tomasiak,et al.  Endothelin-1 in exhaled breath condensate of stable and unstable asthma patients. , 2008, Respiratory medicine.

[98]  B. Sutton,et al.  IgE in allergy and asthma today , 2008, Nature Reviews Immunology.

[99]  H. Hoogsteden,et al.  Altered expression of epithelial junctional proteins in atopic asthma: possible role in inflammation. , 2008, Canadian journal of physiology and pharmacology.

[100]  M. McGuckin,et al.  Structure and function of the polymeric mucins in airways mucus. , 2008, Annual review of physiology.

[101]  Ian D Pavord,et al.  Safety and efficacy of bronchial thermoplasty in symptomatic, severe asthma. , 2007, American journal of respiratory and critical care medicine.

[102]  W. Busse,et al.  A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma. , 2007, American journal of respiratory and critical care medicine.

[103]  D. DeFranco,et al.  Glucocorticoid receptor physiology , 2007, Reviews in Endocrine and Metabolic Disorders.

[104]  W. Henderson,et al.  Mechanisms of disease: Leukotrienes , 2007 .

[105]  Andrew Bush,et al.  Early detection of airway wall remodeling and eosinophilic inflammation in preschool wheezers. , 2007, American journal of respiratory and critical care medicine.

[106]  J. Connolly,et al.  Disruption of E-cadherin-mediated adhesion induces a functionally distinct pathway of dendritic cell maturation. , 2007, Immunity.

[107]  A. Halayko,et al.  Inhibition of allergen-induced airway remodelling by tiotropium and budesonide: a comparison , 2007, European Respiratory Journal.

[108]  H. Kanazawa,et al.  Up-regulation of thrombin activity induced by vascular endothelial growth factor in asthmatic airways. , 2007, Chest.

[109]  I. Pavord,et al.  Vascular remodeling is a feature of asthma and nonasthmatic eosinophilic bronchitis. , 2007, The Journal of allergy and clinical immunology.

[110]  H. Matsumoto,et al.  Comparison of gel contraction mediated by airway smooth muscle cells from patients with and without asthma , 2007, Thorax.

[111]  D. Robinson,et al.  Remodeling and airway hyperresponsiveness but not cellular inflammation persist after allergen challenge in asthma. , 2007, American journal of respiratory and critical care medicine.

[112]  D. Hommes,et al.  Glucocorticoid signaling: a nongenomic mechanism for T-cell immunosuppression. , 2007, Trends in molecular medicine.

[113]  Hans Christian Siersted,et al.  Asthma control during the year after bronchial thermoplasty. , 2007, The New England journal of medicine.

[114]  Q. Hamid,et al.  Tools used to measure airway remodelling in research , 2007, European Respiratory Journal.

[115]  M. Hew,et al.  Expression and activation of TGF-β isoforms in acute allergen-induced remodelling in asthma , 2007, Thorax.

[116]  上田 哲也 Role of small airways in asthma : investigation using high-resolution computed tomography , 2007 .

[117]  J. Whitsett,et al.  IL-1beta disrupts postnatal lung morphogenesis in the mouse. , 2007, American Journal of Respiratory Cell and Molecular Biology.

[118]  J. Bousquet,et al.  Global surveillance, prevention and control of chronic respiratory diseases: a comprehensive approach. , 2007 .

[119]  J. Whitsett,et al.  IL-1β Disrupts Postnatal Lung Morphogenesis in the Mouse , 2007 .

[120]  J. Vernejoux,et al.  Inflammation of bronchial smooth muscle in allergic asthma , 2006, Thorax.

[121]  P. Woodruff,et al.  Quantitative morphology using bronchial biopsies , 2006, European Respiratory Review.

[122]  Yasushi Ito,et al.  Role of RhoA inactivation in reduced cell proliferation of human airway smooth muscle by simvastatin. , 2006, American journal of respiratory cell and molecular biology.

[123]  E. Sutanto,et al.  Intrinsic biochemical and functional differences in bronchial epithelial cells of children with asthma. , 2006, American journal of respiratory and critical care medicine.

[124]  E. Walters,et al.  Effects of inhaled fluticasone on angiogenesis and vascular endothelial growth factor in asthma , 2006, Thorax.

[125]  R. Lipchik Addition of salmeterol to usual asthma pharmacotherapy may increase respiratory related deaths or life threatening experiences , 2006, Evidence-based medicine.

[126]  H. Kubo,et al.  IL-17A promotes the growth of airway epithelial cells through ERK-dependent signaling pathway. , 2006, Biochemical and biophysical research communications.

[127]  K. Racké,et al.  Muscarinic receptors mediate stimulation of human lung fibroblast proliferation. , 2006, American journal of respiratory cell and molecular biology.

[128]  R. Strunk,et al.  Omalizumab for asthma. , 2006, The New England journal of medicine.

[129]  I. Hall,et al.  Glucocorticoids Increase Repair Potential in a Novel in vitro Human Airway Epithelial Wounding Model , 2006, Journal of Clinical Immunology.

[130]  S. Holgate,et al.  The role of the mast cell in the pathophysiology of asthma. , 2006, The Journal of allergy and clinical immunology.

[131]  Reinoud Gosens,et al.  Muscarinic receptor signaling in the pathophysiology of asthma and COPD , 2006, Respiratory research.

[132]  A. McWilliams,et al.  Bronchial thermoplasty for asthma. , 2006, American journal of respiratory and critical care medicine.

[133]  N. Ilhan,et al.  The effects of low dose leukotriene receptor antagonist therapy on airway remodeling and cysteinyl leukotriene expression in a mouse asthma model , 2006, Experimental & Molecular Medicine.

[134]  E. Chi,et al.  Reversal of allergen-induced airway remodeling by CysLT1 receptor blockade. , 2006, American journal of respiratory and critical care medicine.

[135]  D. Hansell,et al.  Can HRCT be used as a marker of airway remodelling in children with difficult asthma? , 2006, Respiratory research.

[136]  G. Arteel,et al.  Metformin Prevents Endotoxin-Induced Liver Injury after Partial Hepatectomy , 2006, Journal of Pharmacology and Experimental Therapeutics.

[137]  I. Pavord,et al.  Evidence of a role of tumor necrosis factor alpha in refractory asthma. , 2006, The New England journal of medicine.

[138]  P. Dorinsky,et al.  The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. , 2006, Chest.

[139]  A. Miller-Larsson,et al.  Lung fibroblast proteoglycan production induced by serum is inhibited by budesonide and formoterol. , 2006, American journal of respiratory cell and molecular biology.

[140]  J. Voynow,et al.  Respiratory tract mucin genes and mucin glycoproteins in health and disease. , 2006, Physiological reviews.

[141]  Q. Hamid,et al.  Evidence of remodeling in peripheral airways of patients with mild to moderate asthma: effect of hydrofluoroalkane-flunisolide. , 2005, The Journal of allergy and clinical immunology.

[142]  I. Tillie‐Leblond,et al.  High-resolution computed tomography scan and airway remodeling in children with severe asthma. , 2005, The Journal of allergy and clinical immunology.

[143]  P. Howarth,et al.  Tumour necrosis factor (TNFalpha) as a novel therapeutic target in symptomatic corticosteroid dependent asthma. , 2005, Thorax.

[144]  P. Howarth,et al.  Altered protein tyrosine phosphorylation in asthmatic bronchial epithelium , 2005, European Respiratory Journal.

[145]  C. Lombard,et al.  A prospective feasibility study of bronchial thermoplasty in the human airway. , 2005, Chest.

[146]  R. Gosens,et al.  Protective effects of tiotropium bromide in the progression of airway smooth muscle remodeling. , 2005, American journal of respiratory and critical care medicine.

[147]  K. Chung,et al.  Effects of ciclesonide and fluticasone propionate on allergen-induced airway inflammation and remodeling features. , 2005, The Journal of allergy and clinical immunology.

[148]  Sarah J. McMillan,et al.  Manipulation of Allergen-Induced Airway Remodeling by Treatment with Anti-TGF-β Antibody: Effect on the Smad Signaling Pathway1 , 2005, The Journal of Immunology.

[149]  T. Haahtela,et al.  Airway remodeling and inflammation in symptomatic infants with reversible airflow obstruction. , 2005, American journal of respiratory and critical care medicine.

[150]  Hiroshi Tanaka,et al.  Quantitative analysis of bronchial wall vascularity in the medium and small airways of patients with asthma and COPD. , 2005, Chest.

[151]  T. Fukuda,et al.  FcεRI-mediated amphiregulin production by human mast cells increases mucin gene expression in epithelial cells , 2005 .

[152]  Guanghui Hu,et al.  Amphiregulin expression in human mast cells and its effect on the primary human lung fibroblasts. , 2005, The Journal of allergy and clinical immunology.

[153]  A. Woodcock,et al.  Wheeze phenotypes and lung function in preschool children. , 2005, American journal of respiratory and critical care medicine.

[154]  T. Fukuda,et al.  FcepsilonRI-mediated amphiregulin production by human mast cells increases mucin gene expression in epithelial cells. , 2005, The Journal of allergy and clinical immunology.

[155]  Sarah J. McMillan,et al.  PathwayAntibody: Effect on the Smad Signaling b Remodeling by Treatment with Anti-TGF-Manipulation of Allergen-Induced Airway , 2005 .

[156]  Jian Li,et al.  Anti-IL-13 monoclonal antibody inhibits airway hyperresponsiveness, inflammation and airway remodeling. , 2004, Cytokine.

[157]  J. Hogg,et al.  Reduction in airway hyperresponsiveness to methacholine by the application of RF energy in dogs. , 2004, Journal of applied physiology.

[158]  S. Orkin,et al.  A Critical Role for Eosinophils in Allergic Airways Remodeling , 2004, Science.

[159]  Stephen T Holgate,et al.  Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma. , 2004, American journal of respiratory and critical care medicine.

[160]  M. Bihl,et al.  Dysfunctional interaction of C/EBPalpha and the glucocorticoid receptor in asthmatic bronchial smooth-muscle cells. , 2004, The New England journal of medicine.

[161]  J. James VASCULAR COMPONENT OF AIRWAY REMODELING IN ASTHMA IS REDUCED BY HIGH DOSE OF FLUTICASONE , 2004, Pediatrics.

[162]  Yasutaka Nakano,et al.  Effect of short-term treatment with inhaled corticosteroid on airway wall thickening in asthma. , 2004, The American journal of medicine.

[163]  P. Woodruff,et al.  Hyperplasia of smooth muscle in mild to moderate asthma without changes in cell size or gene expression. , 2004, American journal of respiratory and critical care medicine.

[164]  J. Bousquet,et al.  Efficacy and safety of a recombinant anti‐immunoglobulin E antibody (omalizumab) in severe allergic asthma , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[165]  Wayne Mitzner,et al.  Airway smooth muscle: the appendix of the lung. , 2004, American journal of respiratory and critical care medicine.

[166]  K. Takatsu,et al.  Role of interleukin-5 and eosinophils in allergen-induced airway remodeling in mice. , 2004, American journal of respiratory cell and molecular biology.

[167]  D. Broide,et al.  Inhibition of airway remodeling in IL-5-deficient mice. , 2004, The Journal of clinical investigation.

[168]  A. Manolis,et al.  Radiofrequency Ablation in Pediatric and Adult Patients: Comparative Results , 2001, Journal of Interventional Cardiac Electrophysiology.

[169]  T. Casale,et al.  Omalizumab treatment downregulates dendritic cell FcεRI expression , 2003 .

[170]  S. Phipps,et al.  Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. , 2003, The Journal of clinical investigation.

[171]  R. Gerszten,et al.  Leukotriene B4 receptor BLT1 mediates early effector T cell recruitment , 2003, Nature Immunology.

[172]  P. Macklem,et al.  Airway wall remodeling: friend or foe? , 2003, Journal of applied physiology.

[173]  M. Aubier,et al.  Airway structural alterations selectively associated with severe asthma. , 2003, American journal of respiratory and critical care medicine.

[174]  Y. Ho,et al.  Stimulation of Airway Mucin Gene Expression by Interleukin (IL)-17 through IL-6 Paracrine/Autocrine Loop* , 2003, The Journal of Biological Chemistry.

[175]  R. Panettieri,et al.  Airway smooth muscle: contraction and beyond. , 2003, The international journal of biochemistry & cell biology.

[176]  B. Barbeau,et al.  Interleukin-4 promotes airway remodeling in asthma: regulation of procollagen I (alpha1) gene by interleukin-4. , 2003, Chest.

[177]  R. Gosens,et al.  Muscarinic M3-receptors mediate cholinergic synergism of mitogenesis in airway smooth muscle. , 2003, American journal of respiratory cell and molecular biology.

[178]  D. Dorscheid,et al.  Corticosteroid-induced apoptosis in mouse airway epithelium: effect in normal airways and after allergen-induced airway inflammation. , 2003, The Journal of allergy and clinical immunology.

[179]  A. Kay,et al.  Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway. , 2003, American journal of respiratory and critical care medicine.

[180]  T. Casale,et al.  Omalizumab treatment downregulates dendritic cell FcepsilonRI expression. , 2003, The Journal of allergy and clinical immunology.

[181]  D. Dorscheid,et al.  Corticosteroid-induced apoptosis of airway epithelium: a potential mechanism for chronic airway epithelial damage in asthma. , 2002, Chest.

[182]  K. Chung,et al.  Matrix metalloproteinase-9 expression in asthma: effect of asthma severity, allergen challenge, and inhaled corticosteroids. , 2002, Chest.

[183]  M. Adachi,et al.  Structural changes of the airway wall impair respiratory function, even in mild asthma. , 2002, Chest.

[184]  P. Howarth,et al.  Asthmatic bronchial epithelium is more susceptible to oxidant-induced apoptosis. , 2002, American journal of respiratory cell and molecular biology.

[185]  D. Johns,et al.  Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma , 2002, Thorax.

[186]  M. Adachi,et al.  Correlation between the bronchial subepithelial layer and whole airway wall thickness in patients with asthma , 2002, Thorax.

[187]  F. Ducharme,et al.  Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children. , 2002, The Cochrane database of systematic reviews.

[188]  E. Chi,et al.  A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model. , 2002, American journal of respiratory and critical care medicine.

[189]  P. Herrlich,et al.  Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor , 2001, The EMBO journal.

[190]  G Salvato,et al.  Quantitative and morphological analysis of the vascular bed in bronchial biopsy specimens from asthmatic and non-asthmatic subjects , 2001, Thorax.

[191]  T. Vandenbos,et al.  Lung epithelial barrier function and wound healing are decreased by IL-4 and IL-13 and enhanced by IFN-gamma. , 2001, American journal of physiology. Cell physiology.

[192]  Steven Sun,et al.  Apoptosis of airway epithelial cells induced by corticosteroids. , 2001, American journal of respiratory and critical care medicine.

[193]  G. Canonica,et al.  Novel Anti-inflammatory Effects of the Inhaled Corticosteroid Fluticasone Propionate During Lung Myofibroblastic Differentiation1 , 2001, The Journal of Immunology.

[194]  I. Adcock,et al.  Glucocorticoid-mediated transrepression is regulated by histone acetylation and DNA methylation. , 2001, European journal of pharmacology.

[195]  R. Pellegrino,et al.  On the functional consequences of bronchial basement membrane thickening. , 2001, Journal of applied physiology.

[196]  R. Marthan,et al.  Tryptase and agonists of PAR-2 induce the proliferation of human airway smooth muscle cells. , 2001, Journal of applied physiology.

[197]  M. Tamm,et al.  Airway smooth muscle cell proliferation is increased in asthma. , 2001, American journal of respiratory and critical care medicine.

[198]  F. Thien,et al.  Effect of a long-acting beta2-agonist over three months on airway wall vascular remodeling in asthma. , 2001, American journal of respiratory and critical care medicine.

[199]  N. Aoike,et al.  Inhaled corticosteroids decrease vascularity of the bronchial mucosa in patients with asthma , 2001, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[200]  J. Westwick,et al.  Therapeutic Effect of IL-13 Immunoneutralization During Chronic Experimental Fungal Asthma1 , 2001, The Journal of Immunology.

[201]  J. Fleisch,et al.  Effects of leukotriene B4 receptor antagonist, LY293111Na, on antigen-induced bronchial hyperresponsiveness and leukocyte infiltration in sensitized guinea pigs , 2001, Inflammation Research.

[202]  K. Sugamura,et al.  Prostaglandin D2 Selectively Induces Chemotaxis in T Helper Type 2 Cells, Eosinophils, and Basophils via Seven-Transmembrane Receptor Crth2 , 2001, The Journal of experimental medicine.

[203]  K. Dabbagh,et al.  IL-13 induces mucin production by stimulating epidermal growth factor receptors and by activating neutrophils. , 2001, American journal of physiology. Lung cellular and molecular physiology.

[204]  K. Chung,et al.  Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsìveness, and the late asthmatic response , 2000, The Lancet.

[205]  J. Black,et al.  The production of extracellular matrix proteins by human passively sensitized airway smooth-muscle cells in culture: the effect of beclomethasone. , 2000, American journal of respiratory and critical care medicine.

[206]  L. Boulet,et al.  Airway hyperresponsiveness, inflammation, and subepithelial collagen deposition in recently diagnosed versus long-standing mild asthma. Influence of inhaled corticosteroids. , 2000, American journal of respiratory and critical care medicine.

[207]  P. Howarth,et al.  Involvement of the epidermal growth factor receptor in epithelial repair in asthma , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[208]  S. Wenzel,et al.  Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. , 1999, American journal of respiratory and critical care medicine.

[209]  M. Hoshino,et al.  Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in asthma. , 1999, The Journal of allergy and clinical immunology.

[210]  S. Holgate,et al.  Immunopathology and human mast cell cytokines. , 1999, Critical reviews in oncology/hematology.

[211]  P. Vadiveloo,et al.  Glucocorticoids inhibit proliferation, cyclin D1 expression, and retinoblastoma protein phosphorylation, but not activity of the extracellular-regulated kinases in human cultured airway smooth muscle. , 1999, American journal of respiratory cell and molecular biology.

[212]  S. Miyamoto,et al.  Augmented acetylcholine‐induced, Rho‐mediated Ca2+ sensitization of bronchial smooth muscle contraction in antigen‐induced airway hyperresponsive rats , 1999, British journal of pharmacology.

[213]  C. Ulrik Outcome of asthma: longitudinal changes in lung function. , 1999, The European respiratory journal.

[214]  T. Horiguchi,et al.  Suppression of Airway Inflammation by Theophylline in Adult Bronchial Asthma , 1999, Respiration.

[215]  J. Vandenbroucke,et al.  Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. , 1999, American journal of respiratory and critical care medicine.

[216]  F. Thien,et al.  Vascularity in asthmatic airways: relation to inhaled steroid dose. , 1999, Thorax.

[217]  D D Donaldson,et al.  Interleukin-13: central mediator of allergic asthma , 1998 .

[218]  P. Jeffery,et al.  Variation in the measurements of basement membrane thickness and inflammatory cell number in bronchial biopsies. , 1998, The European respiratory journal.

[219]  K. Kaestner,et al.  DNA Binding of the Glucocorticoid Receptor Is Not Essential for Survival , 1998, Cell.

[220]  Hoshino,et al.  Inhaled corticosteroid reduced lamina reticularis of the basement membrane by modulation of insulin‐like growth factor (IGF)‐I expression in bronchial asthma , 1998, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[221]  A. Huang,et al.  Glucocorticoids Stimulate p21 Gene Expression by Targeting Multiple Transcriptional Elements within a Steroid Responsive Region of the p21 waf1/cip1 Promoter in Rat Hepatoma Cells* , 1998, The Journal of Biological Chemistry.

[222]  Roberts Cr,et al.  Remodelling of the extracellular matrix in asthma: proteoglycan synthesis and degradation. , 1998 .

[223]  C. Roberts,et al.  Remodelling of the extracellular matrix in asthma: proteoglycan synthesis and degradation. , 1998, Canadian respiratory journal.

[224]  R. Panettieri,et al.  Effects of LTD4 on human airway smooth muscle cell proliferation, matrix expression, and contraction In vitro: differential sensitivity to cysteinyl leukotriene receptor antagonists. , 1998, American journal of respiratory cell and molecular biology.

[225]  I. Virtanen,et al.  Tenascin is increased in airway basement membrane of asthmatics and decreased by an inhaled steroid. , 1997, American journal of respiratory and critical care medicine.

[226]  P. Howarth,et al.  Transforming growth factor-beta 1 in asthma. Measurement in bronchoalveolar lavage fluid. , 1997, American journal of respiratory and critical care medicine.

[227]  A. Casalini,et al.  Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: a placebo-controlled study. , 1997, American journal of respiratory and critical care medicine.

[228]  L. Boulet,et al.  Inhibitory effects of an anti-IgE antibody E25 on allergen-induced early asthmatic response. , 1997, American journal of respiratory and critical care medicine.

[229]  H. Boushey,et al.  The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects. , 1997, American journal of respiratory and critical care medicine.

[230]  F. Finkelman,et al.  Interleukin-4 receptor blockade prevents airway responses induced by antigen challenge in mice. , 1997, The American journal of physiology.

[231]  A. Togias,et al.  Down-regulation of Fc(epsilon)RI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody. , 1997, Journal of immunology.

[232]  R. Pauwels,et al.  GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION , 1996 .

[233]  P. Foster,et al.  Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model , 1996, The Journal of experimental medicine.

[234]  A. Stewart,et al.  The effect of glucocorticoids on proliferation of human cultured airway smooth muscle , 1995, British journal of pharmacology.

[235]  P. Cohen,et al.  Leukotriene D4 facilitates airway smooth muscle cell proliferation via modulation of the IGF axis. , 1995, The American journal of physiology.

[236]  R. Goldie,et al.  MECHANISMS OF INCREASED AIRWAY MICROVASCULAR PERMEABILITY: ROLE IN AIRWAY INFLAMMATION AND OBSTRUCTION , 1995, Clinical and experimental pharmacology & physiology.

[237]  F. Sundler,et al.  Effects of topical budesonide on epithelial restitution in vivo in guinea pig trachea. , 1995, Thorax.

[238]  M. Pruniaux,et al.  Modulation of cytokine-induced eosinophil infiltration by phosphodiesterase inhibitors. , 1995, American journal of respiratory and critical care medicine.

[239]  H. Magnussen,et al.  Theophylline and selective PDE inhibitors as bronchodilators and smooth muscle relaxants. , 1995, The European respiratory journal.

[240]  L. Hendeles,et al.  Theophylline attenuation of airway responses to allergen: comparison with cromolyn metered-dose inhaler. , 1995, The Journal of allergy and clinical immunology.

[241]  E. Gelfand,et al.  In vivo effects of glucocorticoids on IgE production. , 1994, The Journal of allergy and clinical immunology.

[242]  M. Calderón,et al.  Placebo-controlled immunopathologic study of four months of inhaled corticosteroids in asthma. , 1994, American journal of respiratory and critical care medicine.

[243]  C. Page,et al.  Anti-inflammatory effects of low-dose oral theophylline in atopic asthma , 1994, The Lancet.

[244]  T. Haahtela,et al.  A comparative study of the effects of an inhaled corticosteroid, budesonide, and a beta 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomized, double-blind, parallel-group controlled trial. , 1992, The Journal of allergy and clinical immunology.

[245]  P. Jeffery,et al.  Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. A quantitative light and electron microscopic study. , 1992, The American review of respiratory disease.

[246]  K. Tani,et al.  Neutrophil chemotactic factors in the respiratory tract of patients with chronic airway diseases or idiopathic pulmonary fibrosis. , 1992, The American review of respiratory disease.

[247]  J. Bates,et al.  A theoretical study of the effect of airway smooth muscle orientation on bronchoconstriction. , 1990, Journal of applied physiology.

[248]  D. Loegering,et al.  Toxicity of eosinophil cationic proteins for guinea pig tracheal epithelium in vitro. , 1989, The American review of respiratory disease.

[249]  R. Stenling,et al.  Morphological studies of bronchial mucosal biopsies from asthmatics before and after ten years of treatment with inhaled steroids. , 1988, The European respiratory journal.

[250]  S. Kunkel,et al.  Binding of leukotriene C4 to rat lung fibroblasts and stimulation of collagen synthesis in vitro. , 1988, Biochemistry.

[251]  H. Magnussen,et al.  Theophylline has a dose-related effect on the airway response to inhaled histamine and methacholine in asthmatics. , 1987, The American review of respiratory disease.

[252]  B. Cardell [THE PATHOLOGY OF BRONCHIAL ASTHMA]. , 1963, Recenti progressi in medicina.

[253]  M. Dunnill THE PATHOLOGY OF ASTHMA, WITH SPECIAL REFERENCE TO CHANGES IN THE BRONCHIAL MUCOSA , 1960, Journal of clinical pathology.

[254]  M. Kaliner,et al.  On Asthma: Its Pathology and Treatment , 1869, Annals of Internal Medicine.